Is Angioplasty at Centers Without Surgical Backup Safe?

Performing coronary angioplasties at hospitals without surgical backup seems to be safe for a wide variety of patients, from those presenting ST-segment elevation myocardial infarction to those undergoing elective procedures.

 

This work responds to a long-running debate over whether centers without on-site surgery capabilities in case of complications can be considered as referral centers for primary angioplasty (emergency angioplasty) only, or can also perform scheduled procedures.

 

Centers without surgical capabilities have argued in their defense that the performance of scheduled procedures ensured that proper proficiency be maintained for emergency cases.

 

This is the first real-world study showing that it is probably safe to perform coronary angioplasties at centers without surgical backup.

 

The study included data from the Nationwide Inpatient Sample of almost 7 million patients who received an angioplasty in the United States between 2003 and 2012. Overall, 5.7% of the procedures were performed at centers without surgical backup, and the proportion increased with time (1.8% in 2003 vs. 12.7% in 2013; p < 0.001).

 

Hospitals lacking surgical backup performed primary angioplasties more frequently than larger centers with surgical capabilities (34% vs. 20%; p < 0.001).

  • The rate for non-ST-segment elevation acute coronary syndrome was similar (41.8% vs. 42.6%).
  • Scheduled angioplasties were more frequent at centers with surgical capabilities (24.1% vs. 38.2%).
  • Mortality was lower at centers with on-site surgery (1.4% vs. 1.9%; odds ratio [OR] 0.74), but the difference disappeared after researchers adjusted for procedural indication (elective or emergency procedure).

 

The annual angioplasty volume was less than 200 annual cases in two-thirds of the centers without surgical backup.

 

Original title: Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States.

Presenter:  Goel K.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...